Impact of increased alcohol consumption during the COVID-19-related lockdowns on admissions with liver disease, gastrointestinal bleeding and pancreatitis in Melbourne, Victoria

Intern Med J. 2023 May;53(5):830-834. doi: 10.1111/imj.16042. Epub 2023 May 3.

Abstract

This audit collates data on alcohol-related gastrointestinal (GI) admissions at Monash Health, Victoria, during the prolonged, coronavirus disease 2019 (COVID-19)-related lockdown July to October 2020 compared with the same periods in 2019 and 2021. We found a 58% increase in admissions in 2020 and a 16% increase in 2021, which also increased disproportionately to overall health service emergency presentations. Self-reported alcohol consumption increased by 2.5-fold and was greatest in 2020. Clinical severity was unchanged and cirrhosis was the only factor associated with severe disease. This study suggests an association between the pandemic-related lockdown, alcohol consumption and alcohol-related GI hospitalisation. Our study provides support for resourcing and adapting alcohol and other drug services during and beyond the COVID-19 lockdown.

Keywords: COVID-19 pandemic; SARS-CoV-2; alcohol consumption; alcoholic hepatitis; alcoholic liver disease.

MeSH terms

  • Alcohol Drinking
  • COVID-19*
  • Communicable Disease Control
  • Ethanol
  • Gastrointestinal Hemorrhage
  • Hospitalization
  • Humans
  • Liver
  • Pancreatitis*

Substances

  • Ethanol